An experimental vaccine against Alzheimer’s disease has cleared its first
hurdle. Elan Pharmaceuticals of Dublin announced this week that the first 100
patients to receive the vaccine had not suffered any serious side effects. Some
showed an immune response. Codenamed AN-1792, the vaccine is a synthetic version
of the amyloid protein that clogs up the brains of patients. The company now
plans to test the vaccine in the US and Europe.
To continue reading, today with our introductory offers
Advertisement
More from Â鶹´«Ã½
Explore the latest news, articles and features
Popular articles
Trending Â鶹´«Ã½ articles
1
We've found a mysterious substance on Titan and Pluto
2
Most portable air conditioners suck – but there's an easy fix
3
Remarkable fossils rewrite the story of how animals conquered the land
4
Almost the whole of Japan moved eastward after 2011 earthquake
5
A quantum state that lasts forever may finally be within our grasp
6
Faecal transplant makes the brains of old mice act young again
7
Chilling the body with drugs could limit brain damage from stroke
8
Fully autonomous drones have killed human soldiers for the first time
9
Mysterious ‘cold blob’ in the Atlantic suggests the AMOC is weakening
10
These are the extinct humans that live on in your DNA
